Skip to main content

Embecta Corp

Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies

Embecta Corp

Current Price

$3.14

+0.00%

GoodMoat Value

$14.57

364.1% undervalued
Profile
Valuation (TTM)
Market Cap$185.95M
P/E1.66
EV
P/B
Shares Out59.22M
P/Sales0.18
Revenue$1.04B
EV/EBITDA4.22

Embecta Corp (EMBC) Valuation

EMBC Fair Value Estimate

$14.57364.1% undervalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

EMBC Valuation Metrics

FCF$182.40M
FCF Growth Rate-13.62%
EPS Growth (CAGR)-22.25%
WACC10.00%

EMBC Valuation & Fair Value Analysis

Embecta Corp (EMBC) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for Embecta Corp is $14.57. The current stock price is $3.14, suggesting the stock is 364.1% undervalued.

The price-to-earnings (P/E) ratio is 1.66. Price-to-sales ratio is 0.18. Enterprise value to EBITDA is 4.22. PEG ratio is -0.01.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Embecta Corp's intrinsic value.